An independent verification dossier
A sourced record of your licences, operations and claims, the document serious counterparties will ask for anyway.
For licensed growers
You have the licence. Let’s build the evidence.
Regulated buyers do not buy potential. They buy documented, repeatable quality from operators they can trust. We work alongside licensed Colombian growers to build exactly that.
What we bring
Work that makes you easier to say yes to.
GACP and EU-GMP gap analysis
A clear-eyed view of where your practices and records stand against what European processors and auditors expect.
Destination-market intelligence
What importers in Germany, the UK and Australia require, translated into practical steps for a Colombian operation.
Governance and investor readiness
Corporate housekeeping, reporting and documentation that make a company easier to trust, audit and invest in.
Who we work with
A small number of operators, chosen carefully.
- A current psychoactive cultivation licence on the Ministry of Justice register
- Real, verifiable operations: people, a site, records
- An ambition to supply regulated pharmaceutical markets, not grey ones
- Openness to a long-term partnership rather than a quick transaction
- A willingness to separate what is proven from what is planned
We favour long-term, milestone-based partnerships over fees. Every arrangement is agreed in writing and reviewed by lawyers in both countries before it starts.
How it works
From first call to partnership.
- 01
Conversation
An initial call to understand your licences, site, team and goals. No commitment either way.
- 02
Site visit
We visit, meet the team and see the operation first-hand.
- 03
Readiness assessment
We document where you stand and what it would take to reach regulated markets.
- 04
Partnership agreement
If we both want to go further, we agree objective milestones in writing, reviewed by independent counsel in both countries.
Clear boundaries
What we don’t do
- We don’t buy, sell, hold or broker your product.
- We don’t charge commission on sales or introductions tied to cannabis transactions.
- We don’t promise buyers, prices or export dates.
- We don’t publish anything about your company without your agreement.